Enzyme-linked immunosorbent assay of 3 Screen Islet Cell Autoantibody in patients with autoimmune thyroid disease

doi:10.4239/wjd.v15.i5.935

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 15, Issue 5

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (733)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-6) series, Tables (1-2) series.

Item

Count

PDF

WORD

HTML

433

Figures (1-6)

Tables (1-2)

Sum=585

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=94

May 15, 2024 (publication date) through Jul 19, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Observational Study

World J Diabetes. May 15, 2024; 15(5): 935-944
Published online May 15, 2024. doi: 10.4239/wjd.v15.i5.935

Full Size Figure Download Figure

Figure 5 The prevalence of glutamic acid decarboxylase autoantibodies in 3 Screen Islet Cell Autoantibody-positive patients. A: Autoimmune thyroid disease (AITD) with type 1 diabetes (T1D), B: AITD with type 2 diabetes (T2D), C: AITD without diabetes. Among the 3 Screen Islet Cell Autoantibody-positive patients, 12.5% of AITD patients with T1D, 20.0% of AITD patients with T2D, and 20.0% of those without diabetes were negative for glutamic acid decarboxylase autoantibody. AITD: Autoimmune thyroid disease.

Citation: Kawasaki E, Tamai H, Fukuyama T, Sagara Y, Hidaka R, Uchida A, Tojikubo M, Tatsumoto N, Akehi Y, Hiromatsu Y. Enzyme-linked immunosorbent assay of 3 Screen Islet Cell Autoantibody in patients with autoimmune thyroid disease. World J Diabetes 2024; 15(5): 935-944
URL: https://www.wjgnet.com/1948-9358/full/v15/i5/935.htm
DOI: https://dx.doi.org/10.4239/wjd.v15.i5.935